Clinical Trial Update: The Effect of Memantine on Functional Outcomes and Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating memantine for functional outcomes and motor neuron degeneration in amyotrophic lateral sclerosis has completed. The study was …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Namenda (memantine)

Snippet

Sponsor: University of Alberta | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED